Status:
COMPLETED
Long-acting Parasternal Blocks for Analgesia After Cardiac Surgery
Lead Sponsor:
Jewish General Hospital
Conditions:
Coronary Artery Bypass Graft Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a randomized, double-blind, controlled clinical trial is to evaluate the duration of efficacy of parasternal blocks with the use of local anesthetic adjuncts for analgesia after coronary arter...
Detailed Description
This study will randomize patients to either standard pain control protocols or parasternal blocks after coronary artery bypass grafting-only surgery. This study will specifically examine the effectiv...
Eligibility Criteria
Inclusion
- Patients coming for elective and urgent coronary artery bypass (CABG)-only surgery.
Exclusion
- Patients with a history of regular opioid use.
- Patients with a history of chronic pain.
- Patients unable to provide consent.
Key Trial Info
Start Date :
January 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05191745
Start Date
January 26 2022
End Date
June 1 2024
Last Update
June 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jewish General Hospital
Montreal, Quebec, Canada, H3T1E2